194 related articles for article (PubMed ID: 34819573)
1. Incorporation of next-generation sequencing in clinical practice using solid and liquid biopsy for patients with non-Hodgkin's lymphoma.
Bastos-Oreiro M; Suárez-González J; Andrés-Zayas C; Carrión NC; Moreno S; Carbonell D; Chicano M; Muñiz P; Sanz L; Diaz-Crespo FJ; Menarguez J; Diez-Martín JL; Buño I; Martínez-Laperche C
Sci Rep; 2021 Nov; 11(1):22815. PubMed ID: 34819573
[TBL] [Abstract][Full Text] [Related]
2. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
[TBL] [Abstract][Full Text] [Related]
3. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
Matolcsy A; Casali P; Warnke RA; Knowles DM
Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
[TBL] [Abstract][Full Text] [Related]
4. Frequent alteration of MDM2 and p53 in the molecular progression of recurring non-Hodgkin's lymphoma.
Møller MB; Nielsen O; Pedersen NT
Histopathology; 2002 Oct; 41(4):322-30. PubMed ID: 12383214
[TBL] [Abstract][Full Text] [Related]
5. Mutational profiling of circulating tumor DNA and clinical characteristics in lymphoma: Based on next generation sequencing.
Hou Y; Zi J; Liu S; Ge Q; Ge Z
Mol Carcinog; 2023 Feb; 62(2):200-209. PubMed ID: 36300887
[TBL] [Abstract][Full Text] [Related]
6. Higher-grade transformation of follicle center lymphoma is associated with somatic mutation of the 5' noncoding regulatory region of the BCL-6 gene.
Lossos IS; Levy R
Blood; 2000 Jul; 96(2):635-9. PubMed ID: 10887128
[TBL] [Abstract][Full Text] [Related]
7. Performance of the cobas EZH2 mutation test on clinical samples from non-Hodgkin lymphoma patients.
Shyu JY; Schlag PA; Karwowska SM; Manohar CF; Truong HM; Longshore JW; Zhang G
PLoS One; 2023; 18(12):e0292251. PubMed ID: 38096164
[TBL] [Abstract][Full Text] [Related]
8. Indications of next-generation sequencing in non-Hodgkin's lymphoma.
Heimann P; Dewispelaere L
Curr Opin Oncol; 2020 Sep; 32(5):391-397. PubMed ID: 32675596
[TBL] [Abstract][Full Text] [Related]
9. Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma.
Camus V; Sarafan-Vasseur N; Bohers E; Dubois S; Mareschal S; Bertrand P; Viailly PJ; Ruminy P; Maingonnat C; Lemasle E; Stamatoullas A; Picquenot JM; Cornic M; Beaussire L; Bastard C; Frebourg T; Tilly H; Jardin F
Leuk Lymphoma; 2016 Sep; 57(9):2171-9. PubMed ID: 26883583
[TBL] [Abstract][Full Text] [Related]
10. A new method to detect loss of heterozygosity using cohort heterozygosity comparisons.
Green MR; Jardine P; Wood P; Wellwood J; Lea RA; Marlton P; Griffiths LR
BMC Cancer; 2010 May; 10():195. PubMed ID: 20462409
[TBL] [Abstract][Full Text] [Related]
11. Transformation of follicular lymphoma.
Lossos IS; Gascoyne RD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):147-63. PubMed ID: 21658615
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma.
Nagy Á; Bátai B; Balogh A; Illés S; Mikala G; Nagy N; Kiss L; Kotmayer L; Matolcsy A; Alpár D; Masszi T; Masszi A; Bödör C
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32668764
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy-based circulating tumour (ct)DNA analysis of a spectrum of myeloid and lymphoid malignancies yields clinically actionable results.
Mata DA; Lee JK; Shanmugam V; Marcus CB; Schrock AB; Williams EA; Ritterhouse LL; Hickman RA; Janovitz T; Patel NR; Kroger BR; Ross JS; Mirza KM; Oxnard GR; Vergilio JA; Elvin JA; Benhamida JK; Decker B; Xu ML
Histopathology; 2024 Jun; 84(7):1224-1237. PubMed ID: 38422618
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive monitoring of diffuse large B-cell lymphoma by cell-free DNA high-throughput targeted sequencing: analysis of a prospective cohort.
Bohers E; Viailly PJ; Becker S; Marchand V; Ruminy P; Maingonnat C; Bertrand P; Etancelin P; Picquenot JM; Camus V; Menard AL; Lemasle E; Contentin N; Leprêtre S; Lenain P; Stamatoullas A; Lanic H; Libraire J; Vaudaux S; Pepin LF; Vera P; Tilly H; Jardin F
Blood Cancer J; 2018 Aug; 8(8):74. PubMed ID: 30069017
[TBL] [Abstract][Full Text] [Related]
15. Mutations or copy number losses of CD58 and TP53 genes in diffuse large B cell lymphoma are independent unfavorable prognostic factors.
Cao Y; Zhu T; Zhang P; Xiao M; Yi S; Yang Y; Li Q; Ling S; Wang Y; Gao L; Zhu L; Wang J; Wang N; Huang L; Zhang P; Zhai Q; Qiu L; Zhou J
Oncotarget; 2016 Dec; 7(50):83294-83307. PubMed ID: 27825110
[TBL] [Abstract][Full Text] [Related]
16. Clinical impact of molecular features in diffuse large B-cell lymphoma and follicular lymphoma.
Pon JR; Marra MA
Blood; 2016 Jan; 127(2):181-6. PubMed ID: 26447189
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutation of the 5' noncoding region of the BCL-6 gene is associated with intraclonal diversity and clonal selection in histological transformation of follicular lymphoma.
Szereday Z; Csernus B; Nagy M; László T; Warnke RA; Matolcsy A
Am J Pathol; 2000 Mar; 156(3):1017-24. PubMed ID: 10702417
[TBL] [Abstract][Full Text] [Related]
18. Mutation Profiling of Malignant Lymphoma by Next-Generation Sequencing of Circulating Cell-Free DNA.
Sun P; Chen C; Xia Y; Wang Y; Liu PP; Bi XW; Shao YW; Ou QX; Wu X; Yang H; Nie M; Zhang XW; Li ZM; Jiang WQ
J Cancer; 2019; 10(2):323-331. PubMed ID: 30719126
[No Abstract] [Full Text] [Related]
19. The value of liquid biopsy in diagnosis and monitoring of diffuse large b-cell lymphoma: recent developments and future potential.
Camus V; Jardin F; Tilly H
Expert Rev Mol Diagn; 2017 Jun; 17(6):557-566. PubMed ID: 28415895
[TBL] [Abstract][Full Text] [Related]
20. Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT.
Jiménez-Ubieto A; Poza M; Martin-Muñoz A; Ruiz-Heredia Y; Dorado S; Figaredo G; Rosa-Rosa JM; Rodriguez A; Barcena C; Navamuel LP; Carrillo J; Sanchez R; Rufian L; Juárez A; Rodriguez M; Wang C; de Toledo P; Grande C; Mollejo M; Casado LF; Calbacho M; Baumann T; Rapado I; Gallardo M; Sarandeses P; Ayala R; Martínez-López J; Barrio S
Leukemia; 2023 Mar; 37(3):659-669. PubMed ID: 36596983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]